Processa Pharmaceuticals

(NASDAQ) PCSA

Current Price$2.65

Market Cap$7.18M

Since IPO (2017)-100%

5 Year-100%

1 Year-58%

1 Month+7%

Processa Pharmaceuticals Financials at a Glance

Market Cap

$7.18M

Revenue (TTM)

$0.00

Net Income (TTM)

$13.56M

EPS (TTM)

$-16.87

P/E Ratio

-0.16

Dividend

$0.00

Beta (Volatility)

0.85 (Low)

Dividend

$0.00

Beta (Volatility)

0.85 (Low)

Price

$2.65

Volume

Open

$2.74

Price

$2.65

Volume

Open

$2.74

Previous Close

$2.65

Daily Range

$2.65 - $2.74

52-Week Range

$1.76 - $19.63

Dividend

$0.00

Beta (Volatility)

0.85 (Low)

Price

$2.65

Volume

Open

$2.74

Previous Close

$2.65

Daily Range

$2.65 - $2.74

52-Week Range

$1.76 - $19.63

PCSA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Processa Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

George K. Ng

Website

www.processapharmaceuticals.com

Headquarters

Hanover, MD 21076, US

PCSA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-373%

Return on Capital

-3%

Return on Assets

-2%

Earnings Yield

-6.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.18M

Shares Outstanding

2.66M

Volume

Avg. Volume

55.88K

Financials (TTM)

Gross Profit

$1.20K

Operating Income

$13.99M

EBITDA

$13.99M

Operating Cash Flow

$11.39M

Capital Expenditure

$5.00

Free Cash Flow

$11.39M

Cash & ST Invst.

$5.54M

Total Debt

$0.00

Processa Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$301.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$7.18M

N/A

Market Cap/Employee

$718.21K

N/A

Employees

N/A

Net Income

$3.36M

-23.1%

EBITDA

$3.75M

-37.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$5.54M

+395.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.74%

N/A

Return on Invested Capital

-2.51%

N/A

Free Cash Flow

$5.63M

-150.5%

Operating Cash Flow

$5.63M

-150.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CTXRCitius Pharmaceuticals, Inc.

CTXRCitius Pharmaceuticals, Inc.$0.70+16.96%

BCTXBriaCell Therapeutics Corp.

BCTXBriaCell Therapeutics Corp.$4.18+3.98%

CRISCuris, Inc.

CRISCuris, Inc.$0.60+6.88%

HOTHHoth Therapeutics, Inc.

HOTHHoth Therapeutics, Inc.$0.75+4.42%

MBRXMoleculin Biotech, Inc.

MBRXMoleculin Biotech, Inc.$2.56+1.99%

ENTOEntero Therapeutics, Inc.

ENTOEntero Therapeutics, Inc.$2.85-5.00%

ALLRAllarity Therapeutics, Inc.

ALLRAllarity Therapeutics, Inc.$1.35-2.17%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.47+0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.54+0.03%

INTCIntel

INTCIntel$94.48-0.00%

NOKNokia

NOKNokia$12.91+0.04%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$51.65-0.03%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$667.74+0.01%

TSLATesla

TSLATesla$381.63+0.02%

Questions About PCSA

What is the current price of Processa Pharmaceuticals?

Processa Pharmaceuticals is trading at $2.65 per share.

What is the 52-week range for Processa Pharmaceuticals?

Over the past 52 weeks, Processa Pharmaceuticals has traded between $1.76 and $19.63.

How much debt does Processa Pharmaceuticals have?

As of the most recent reporting period, Processa Pharmaceuticals reported total debt of N/A.

How much cash does Processa Pharmaceuticals have on hand?

Processa Pharmaceuticals reported $5.54M in cash and cash equivalents in its most recent financial results.

What is Processa Pharmaceuticals’s dividend yield?

Processa Pharmaceuticals does not currently have a dividend yield.

Processa Pharmaceuticals

Processa Pharmaceuticals Financials at a Glance

PCSA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Processa Pharmaceuticals

PCSA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Processa Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PCSA

What is the current price of Processa Pharmaceuticals?

What is the 52-week range for Processa Pharmaceuticals?

How much debt does Processa Pharmaceuticals have?

How much cash does Processa Pharmaceuticals have on hand?

What is Processa Pharmaceuticals’s dividend yield?

Premium Investing Services